These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8904135)

  • 21. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of cefpodoxime proxetil in pediatric field].
    Kimura S; Yokoyama M; Kudo M; Aoyama R; Okamoto T; Tsushima N; Onodera N; Ikeda Y
    Jpn J Antibiot; 1989 Jul; 42(7):1477-87. PubMed ID: 2810724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of cefpodoxime proxetil (RU 51807): a comparative disk diffusion study on isolates from geriatric patients.
    Ottomano C; Frugoni S; Berlusconi A; Miseferi G; Mattina R; Anelli M
    J Chemother; 1991 Jan; 3 Suppl 1():62-5. PubMed ID: 12041788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute maxillary sinusitis--comparing cefpodoxime proxetil with amoxicillin.
    von Sydow C; Savolainen S; Söderqvist A
    Scand J Infect Dis; 1995; 27(3):229-34. PubMed ID: 8539546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
    Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
    Phillips H; Van Hook CJ; Butler T; Todd WM
    Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
    Tack KJ; Wilks NE; Semerdjian G; Frazier CH; Shirin K; Puopolo A; Crossland SG; Goffe BS; Millikan L
    Drugs; 1991; 42 Suppl 3():51-6. PubMed ID: 1726208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
    Zuck P; Rio Y; Ichou F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefpodoxime proxetil: a new, broad-spectrum, oral cephalosporin.
    Chocas EC; Paap CM; Godley PJ
    Ann Pharmacother; 1993 Nov; 27(11):1369-77. PubMed ID: 8286813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [(New antimicrobial agent series XLIV): cefpodoxime proxetil].
    Kumazawa J
    Jpn J Antibiot; 1993 Sep; 46(9):749-72. PubMed ID: 8254896
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bacterial infections of the respiratory tract and of the ENT area. Cephalosporin in general practice is effective].
    Hanke K; Blum SP
    MMW Fortschr Med; 2002 Mar; 144(13):36. PubMed ID: 12001587
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 33. Third-generation cephalosporins for upper respiratory tract infections.
    van Niekerk CH
    S Afr Med J; 2002 Oct; 92(10):745-6; author reply 746. PubMed ID: 12432789
    [No Abstract]   [Full Text] [Related]  

  • 34. Cefpodoxime proxetil.
    Del Beccaro MA
    Pediatr Ann; 1993 Mar; 22(3):187-92, 195-6. PubMed ID: 8464650
    [No Abstract]   [Full Text] [Related]  

  • 35. A clinical and bacteriologic evaluation of cefamandole therapy in serious skin and skin structure infections.
    Glanges E; Crenshaw CA; Webber CE
    Surg Gynecol Obstet; 1980 Apr; 150(4):502-6. PubMed ID: 7361234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials with cefoperazone in the field of surgery in Japan.
    Shibata K
    Clin Ther; 1980; 3(Spec Issue):173-89. PubMed ID: 6446393
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.
    Periti P; Novelli A; Schildwachter G; Schmidt-Gayk H; Ryo Y; Zuck P
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].
    Hanke K; Blum SP
    Fortschr Med Orig; 2002; 120(1):21-8. PubMed ID: 14518354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of cefpodoxime in respiratory tract infections].
    Fukuhara H; Irabu Y; Kakazu T; Nakamura H; Shigeno Y; Saito A; Owan T; Oshiro H; Miyaguni T; Nakasone K
    Jpn J Antibiot; 1993 Jan; 46(1):53-9. PubMed ID: 8455331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.